- Home
- SIEB vs CTOR Comparison
SIEB vs CTOR Comparison
Compare SIEB & CTOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIEB
- CTOR
- Stock Information
- Founded
- SIEB 1886
- CTOR 2021
- Country
- SIEB United States
- CTOR United States
- Employees
- SIEB N/A
- CTOR N/A
- Industry
- SIEB Investment Bankers/Brokers/Service
- CTOR
- Sector
- SIEB Finance
- CTOR
- Exchange
- SIEB Nasdaq
- CTOR NYSE
- Market Cap
- SIEB 166.1M
- CTOR 146.6M
- IPO Year
- SIEB N/A
- CTOR N/A
- Fundamental
- Price
- SIEB $4.05
- CTOR $2.29
- Analyst Decision
- SIEB
- CTOR Buy
- Analyst Count
- SIEB 0
- CTOR 2
- Target Price
- SIEB N/A
- CTOR $6.00
- AVG Volume (30 Days)
- SIEB 97.9K
- CTOR 2.6M
- Earning Date
- SIEB 08-13-2025
- CTOR 08-11-2025
- Dividend Yield
- SIEB N/A
- CTOR N/A
- EPS Growth
- SIEB 117.05
- CTOR N/A
- EPS
- SIEB 0.46
- CTOR N/A
- Revenue
- SIEB $92,064,000.00
- CTOR N/A
- Revenue This Year
- SIEB N/A
- CTOR N/A
- Revenue Next Year
- SIEB N/A
- CTOR N/A
- P/E Ratio
- SIEB $8.71
- CTOR N/A
- Revenue Growth
- SIEB 21.82
- CTOR N/A
- 52 Week Low
- SIEB $1.41
- CTOR $0.55
- 52 Week High
- SIEB $5.77
- CTOR $49.00
- Technical
- Relative Strength Index (RSI)
- SIEB 47.91
- CTOR N/A
- Support Level
- SIEB $3.76
- CTOR N/A
- Resistance Level
- SIEB $4.11
- CTOR N/A
- Average True Range (ATR)
- SIEB 0.21
- CTOR 0.00
- MACD
- SIEB 0.03
- CTOR 0.00
- Stochastic Oscillator
- SIEB 71.91
- CTOR 0.00
About SIEB Siebert Financial Corp.
Siebert Financial Corp is a diversified financial services firm and provides a full range of brokerage and financial advisory services including securities brokerage, investment advisory and insurance offerings, and corporate stock plan administration solutions. The firm mainly provides online and traditional brokerage and related services to retail investors and also acts as an investment advisor for its subsidiary. The company operates in the securities brokerage and asset management industry. It also engages in Insurance services, Robo-advisory technology, and Prime brokerage business through its subsidiaries.
About CTOR CITIUS ONCOLOGY INC
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.